The Spanish stock market experienced another week in which purchases clearly prevailed over sales, leading the Ibex to attack 12,000 points, which The strategic portfolio has not been foreign and is already sufficient a capital gain of 44% since its creation three years ago.
This week one of the most notable stocks was Fluidra, whose shares rose by more than 5%, reaching maximums never seen since May approximately 23.4 euros. However, for the analysis houses that follow it, there is little more to gain from Catalan since, on average, they set a price target lower than the current level. For this reason, from the active management tool, it was decided to place a stop protection of benefits in the 23.12 euroslevel which guarantees a profitability of 5%which rises to 10% if we count dividends charge.
In addition to this movement, the highlight of this week was that Viscofan already listed in the field of Highs from July last yearabove 63 euros per share. The portfolio He already gains more than 7% with this strategy, in which analysts still estimate him an additional journey of more than 12%up to 71.7 euros where, on average, they set their valuation. In doing so, it would also be considered to put in place a protective stop in the coming weeks.
Sacyr And Cellnex They also experienced significant increases this week, of around 3%.
